Feb 22, 2010 –
Shanghai, China |
Health Vision Enterprise appoints Rogers Luo as National Sales Director
|
December 2, 2009 –
Shanghai, China |
Health Vision’s targeted products have all been successfully listed in China’s National Drug Reimbursement List
|
October 26, 2009 –
Shanghai, China |
Management buyout of Stada’s 51% share of Health Vision Enterprise Ltd to re gain 100% control
|
Jul 30, 2008 –
Tokyo, Japan |
Health Vision Enterprise appoints Eisai China Inc. as the marketing agent
for Alpha Lipon®, a company with a focus in
endocrinology
|
Oct 28, 2007 –
Nan Jing, China |
Health Vision (Nan Jing) Medicine Company Limited obtains GSP
license
|
April 28, 2007 –
Nan Jing, China |
Obtain business license for Health Vision (Nan Jing) Medicine
company, a wholly foreign owned enterprise allowing importation,
logistic distribution and licensing-in products
|
March 24, 2007 –
Shanghai, China |
Health Vision Enterprise executes exclusive marketing agreement with Shanghai
RAAS for their innovative haemostatic product, FibinGluRAAS®, a
dual syringe containing fibrinogen and thrombin
|